Per Karlen

Danderyd, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.

Journal: Therapeutic advances in gastroenterology

Published: December 12, 2022

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG.

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG.

Journal: Scandinavian journal of gastroenterology

Published: August 20, 2021

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.

Journal: Therapeutic advances in gastroenterology

Published: March 12, 2021

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Clinical effectiveness of golimumab in Crohn's disease: an observational study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Journal: Scandinavian journal of gastroenterology

Published: October 25, 2018

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Journal: Scandinavian journal of gastroenterology

Published: April 01, 2017

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study.

Journal: European journal of gastroenterology & hepatology

Published: July 30, 2016

Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients.

Randomised, Double-blind, Placebo-controlled Trial of CCR9-targeted Leukapheresis Treatment of Ulcerative Colitis Patients.

Journal: Journal of Crohn's & colitis

Published: October 22, 2015

Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.

Experiences of complementary and alternative medicine in patients with inflammatory bowel disease - a qualitative study.

Journal: BMC complementary and alternative medicine

Published: June 05, 2014

Naïve T cells in the gut: how to really find them?

Naïve T cells in the gut: how to really find them?

Journal: Scandinavian journal of gastroenterology

Published: February 04, 2014

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.

Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.

Journal: Scandinavian journal of gastroenterology

Published: November 06, 2013

Mesalazine-induced renal calculi.

Mesalazine-induced renal calculi.

Journal: The American journal of case reports

Published: August 29, 2013

Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.

Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients.

Journal: Alimentary pharmacology & therapeutics

Published: April 25, 2013

Showing 1-12 of 16

Last Updated: 09/26/2026